Preliminary updated results of a phase I/II trial using trimodality therapy in patients with post-prostatectomy high risk pathologic (p) T2-3N0M0 prostate cancer

被引：0
|
作者：
Kumar, Parvesh
Van Veldhuizen, Peter J.
Thompson, Mark
Shen, Xinglei
Coster, James
Pinskl, Jacek
机构：
[1] Univ Kansas, Sch Med, Dept Radiat Oncol, Kansas City, KS USA
[2] Univ Kansas, Sch Med, Div Med Oncol, Westwood, KS USA
[3] Univ So Calif, Keck Sch Med, Div Med Oncol, Los Angeles, CA 90033 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 15期
关键词：
D O I：
10.1200/jco.2014.32.15_suppl.e16084
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e16084
引用
收藏
页数：1
相关论文
共 49 条
  • [1] Results of a phase I-II trial using tri-modality therapy in patients with post-prostatectomy high risk pathologic (p) T2-3N0M0 prostate cancer.
    Kumar, Parvesh
    Van Veldhuizen, Peter
    Thompson, Mark
    Shen, Xinglei
    Pinski, Jacek K.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [2] Preliminary Results of a Nearly Completed Phase 1-2 Trial Using Trimodality Therapy in Patients With Post Prostatectomy High-Risk Pathologic (p) T2-3N0M0 Prostate Cancer
    Kumar, P.
    Veldhuizen, P.
    Thompson, M. A.
    Shen, X.
    Coster, J.
    Pinski, J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03): : E250 - E250
  • [3] Trimodality Therapy Is Tolerable and Feasible in Patients With Postprostatectomy High-Risk Pathologic (p) T2-3N0M0 Prostate Cancer: Results of a Phase 1-2 Trial
    Kumar, P.
    Veldhuizen, P.
    Thompson, M.
    Shen, X.
    Pinski, J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : S186 - S186
  • [4] Preliminary Results of an On-Going Phase 1/2 Trial of Trimodality Therapy Using Hormonal Therapy, Radiation Therapy (RT), and Concurrent Docetaxel in Patients With High-Risk Pathologic T2-3-N0M0 Prostate Cancer
    Kumar, P.
    Veldhuizen, P.
    Thompson, M.
    Shen, X.
    Pinski, J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (02): : S389 - S390
  • [5] Recently Updated Preliminary Results of an On-Going Phase 1/2 Trial Using Trimodality Therapy in Patients With Postprostatectomy High-Risk Pathologic (p) T2-3NOMO Prostate Cancer
    Kumar, P.
    Veldhuizen, P. V.
    Thompson, M.
    Shen, X.
    Coster, J.
    Pinski, J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S457 - S457
  • [6] 4-year follow-up results of a European prospective randomized study on neoadjuvant hormonal therapy prior to radical prostatectomy in T2-3N0M0 prostate cancer
    Schulman, CC
    Debruyne, FMJ
    Forster, G
    Selvaggi, FP
    Zlotta, AR
    Witjes, WPJ
    EUROPEAN UROLOGY, 2000, 38 (06) : 706 - 713
  • [7] Results of a European randomized study comparing radical prostatectomy and radical prostatectomy plus neoadjuvant hormonal combination therapy in stage T2-3N0M0 prostatic carcinoma
    Witjes, WPJ
    Schulman, CC
    Debruyne, FMJ
    MOLECULAR UROLOGY, 1998, 2 (03) : 181 - 185
  • [8] Postoperative Radiation Therapy in Pathologic T2-3N0M0 Thoracic Esophageal Squamous Cell Carcinoma: Interim Report of a Prospective, Phase 3, Randomized Controlled Study
    Deng, W.
    Yang, J.
    Xiao, Z.
    Wang, X.
    Zhou, Z.
    Zhang, H.
    Chen, D.
    Feng, Q.
    Liang, J.
    Lv, J.
    Zhang, T.
    Bi, N.
    Wang, W.
    Deng, L.
    Hui, Z.
    Wang, L.
    He, J.
    Gao, S.
    Xue, Q.
    Mao, Y.
    Sun, K.
    Liu, X.
    Fang, D.
    Li, J.
    Wang, D.
    Mou, J.
    Zhao, J.
    Li, Z.
    Lei, W.
    Wang, Y.
    Chen, X.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : S190 - S191
  • [9] Ultra-early versus early salvage androgen deprivation therapy for post-prostatectomy biochemical recurrence in pT2-4N0M0 prostate cancer
    Satoru Taguchi
    Hiroshi Fukuhara
    Takeshi Azuma
    Motofumi Suzuki
    Tetsuya Fujimura
    Tohru Nakagawa
    Akira Ishikawa
    Haruki Kume
    Yasuhiko Igawa
    Yukio Homma
    BMC Urology, 14
  • [10] Ultra-early versus early salvage androgen deprivation therapy for post-prostatectomy biochemical recurrence in pT2-4N0M0 prostate cancer
    Taguchi, Satoru
    Fukuhara, Hiroshi
    Azuma, Takeshi
    Suzuki, Motofumi
    Fujimura, Tetsuya
    Nakagawa, Tohru
    Ishikawa, Akira
    Kume, Haruki
    Igawa, Yasuhiko
    Homma, Yukio
    BMC UROLOGY, 2014, 14
12345